Drugs / IP10.C8
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00824980 | Jan → Sep 2009 | psoriasis | Immune Technologies & Medicine GmbH | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IP10.C8 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00824980 ↗ |
| Action | Inhibit | “topical treatment simultaneously inhibiting Dipeptidyl Peptidase IV and Aminopeptidase N” NCT00824980 ↗ |
| Route | Topical | “topical treatment” NCT00824980 ↗ |